These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11260349)

  • 21. Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients.
    Sundelin K; Seal D; Gardner S; Ropo A; Geldsetzer K; Lokkila J; Stenevi U
    Acta Ophthalmol; 2009 Mar; 87(2):160-5. PubMed ID: 18771480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical pharmacology and efficacy of levofloxacin in elderly patients].
    Aoki N; Usuda Y; Koda Y; Takasawa T; Wakabayashi N; Hayashi S; Nitta I; Honma C; Watanabe K
    Jpn J Antibiot; 1992 May; 45(5):530-8. PubMed ID: 1512939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
    Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology].
    Trinchieri A; Mangiarotti B; Lizzano R
    Arch Ital Urol Androl; 2002 Mar; 74(1):33-9. PubMed ID: 12053449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose.
    Pea F; Marioni G; Pavan F; Staffieri C; Bottin R; Staffieri A; Furlanut M
    Pharmacol Res; 2007 Jan; 55(1):38-41. PubMed ID: 17092740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases.
    Tanigawara Y; Nomura H; Kagimoto N; Okumura K; Hori R
    Biol Pharm Bull; 1995 Feb; 18(2):315-20. PubMed ID: 7742805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations.
    Ohyama M; Furuta S; Ueno K; Katsuda K; Nobori T; Kiyota R; Miyazaki Y
    Arch Otolaryngol Head Neck Surg; 1999 Mar; 125(3):337-40. PubMed ID: 10190808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal effect of levofloxacin on strains with equal susceptibility in an in vitro urinary bladder model.
    Takahashi S; Sano M; Nishimura M; Matsukawa M; Mikami M; Hirose T; Tsukamoto T
    Chemotherapy; 1998; 44(5):337-42. PubMed ID: 9732150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
    Walters T; Rinehart M; Krebs W; Holdbrook M
    Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.
    Ren H; Li X; Ni ZH; Niu JY; Cao B; Xu J; Cheng H; Tu XW; Ren AM; Hu Y; Xing CY; Liu YH; Li YF; Cen J; Zhou R; Xu XD; Qiu XH; Chen N
    Int Urol Nephrol; 2017 Mar; 49(3):499-507. PubMed ID: 28108978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer.
    Sowinski KM; Lucksiri A; Kays MB; Scott MK; Mueller BA; Hamburger RJ
    Am J Kidney Dis; 2003 Aug; 42(2):342-9. PubMed ID: 12900817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Penetration of levofloxacin in bile].
    Mizuno A; Suzuki T; Taniguchi M; Yura J; Shinagawa N; Ishikawa S; Mashita K; Suzui K; Ishikawa M; Ishihara H
    Jpn J Antibiot; 1992 May; 45(5):569-75. PubMed ID: 1512943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofloxacin-induced seizures in rats.
    Ishiwata Y; Son K; Itoga Y; Yasuhara M
    Biol Pharm Bull; 2007 Apr; 30(4):745-50. PubMed ID: 17409514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue.
    Sadahira T; Wada K; Ikawa K; Morikawa N; Kurahashi H; Yoshioka T; Ariyoshi Y; Kobayashi Y; Araki M; Ishii A; Watanabe M; Uehara S; Watanabe T; Nasu Y
    J Infect Chemother; 2017 Apr; 23(4):214-217. PubMed ID: 28089362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats.
    Akahane K; Ohkawara S; Nomura M; Kato M
    Fundam Appl Toxicol; 1996 Feb; 29(2):280-6. PubMed ID: 8742326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
    Pea F; Di Qual E; Cusenza A; Brollo L; Baldassarre M; Furlanut M
    Clin Pharmacokinet; 2003; 42(6):589-98. PubMed ID: 12793843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
    Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
    Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study.
    Lin YH; Hou CP; Chen TH; Juang HH; Chang PL; Yang PS; Lin YS; Chen CL; Tsui KH
    Clin Interv Aging; 2017; 12():535-541. PubMed ID: 28356725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Elevation of serum and urine tumor necrosis factor levels after transurethral resection of the prostate].
    Irie A; Lee KE; Kadowaki K; Toda K; Yamada Y
    Nihon Hinyokika Gakkai Zasshi; 1999 Apr; 90(4):502-8. PubMed ID: 10355252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.